Brief: Baudax Bio Says Announced Pricing Of Its Previously Announced Underwritten Public Offering Of 3.5 Million Shares Of Common Stock
25/02/2022 04:25
Feb 24 (Reuters) - Baudax Bio Inc BXRX.O :
* ANNOUNCED PRICING OF ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN
PUBLIC OFFERING OF 3.5 MILLION SHARES OF COMMON STOCK
Source text for Eikon: ID:nGNXFxbrz
Further company coverage: BXRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer